9/12/2023

Fat Emulsion

Reason for the Shortage

- Baxter has Clinolipid presentations available.
- BBraun has Nutrilipid presentations available.
- Fresenius Kabi has Smoflipid available. Fresenius Kabi launched Intralipid presentations in June 2023.

Available Products

- Clinolipid emulsion, Baxter, 20%, 100 mL Clarity polyolefin bag, 15 count, NDC 00338-9540-05
- Clinolipid emulsion, Baxter, 20%, 1000 mL Clarity polyolefin bag, 6 count, NDC 00338-9540-08
- Clinolipid emulsion, Baxter, 20%, 250 mL Clarity polyolefin bag, 10 count, NDC 00338-9540-06
- Clinolipid emulsion, Baxter, 20%, 500 mL Clarity polyolefin bag, 12 count, NDC 00338-9540-07
- Intralipid emulsion, Fresenius Kabi, 20%, 1,000 mL freeflex container, 6 count, NDC 65219-0539-10
- Intralipid emulsion, Fresenius Kabi, 20%, 100 mL freeflex container, 10 count, NDC 65219-0531-10
- Intralipid emulsion, Fresenius Kabi, 20%, 250 mL freeflex container, 10 count, NDC 65219-0533-25
- Intralipid emulsion, Fresenius Kabi, 20%, 500 mL freeflex container, 12 count, NDC 65219-0535-50
- Intralipid emulsion, Fresenius Kabi, 30%, 500 mL freeflex container, 12 count, NDC 65219-0537-50
- Nutrilipid emulsion, BBraun, 20%, 1000 mL flexible container, 8 count, NDC 00264-4460-00
- Nutrilipid emulsion, BBraun, 20%, 250 mL flexible container, 12 count, NDC 00264-4460-30
- Nutrilipid emulsion, BBraun, 20%, 500 mL flexible container, 12 count, NDC 00264-4460-10
- Smoflipid emulsion, Fresenius Kabi, 20%, 1,000 mL pharmacy bulk package bag, 10 count, NDC 63323-0820-10
- Smoflipid emulsion, Fresenius Kabi, 20%, 100 mL bag, 10 count, NDC 63323-0820-00
- Smoflipid emulsion, Fresenius Kabi, 20%, 250 mL bag, 10 count, NDC 63323-0820-74
- Smoflipid emulsion, Fresenius Kabi, 20%, 500 mL bag, 10 count, NDC 63323-0820-50

Estimated Resupply Dates

- All marketed presentations are available.

Updated

Updated September 12, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created August 18, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.